Our Services
Medical Information
Helpful Resources
Published on: 10/26/2026
Lexapro (escitalopram) side effects often peak during the first one to two weeks, with nausea, headache, drowsiness or insomnia, dry mouth, dizziness, increased sweating, and temporary jitteriness or heightened anxiety being most common as your body adjusts. Many of these early effects ease within two to four weeks, while longer-term issues such as sexual side effects, weight changes, emotional blunting, fatigue, or vivid dreams can persist and may need a dose adjustment or medication change. Warning signs like worsening mood, new or increased suicidal thoughts, agitation, high fever with muscle rigidity or confusion (possible serotonin syndrome), or unusual bleeding need prompt medical attention, and stopping suddenly can trigger discontinuation symptoms. Timelines, risk factors, and what counts as normal versus concerning vary by person, so there are several important details to consider below before deciding whether to wait it out or contact your prescriber.
If you are unsure whether what you feel is an expected adjustment or something that needs attention, a free, instant, online symptom check can help you sort your symptoms, flag possible red flags, and understand which next steps and questions to bring to your doctor.
Last reviewed for medical accuracy: 10/22/2026
Escitalopram (brand name Lexapro) is a commonly prescribed SSRI (selective serotonin reuptake inhibitor) used to treat depression and anxiety. Like all medications, it can cause side effects. Knowing what to expect during the first two weeks and beyond can help you feel more in control. If you ever have severe or worrying symptoms, speak to a doctor right away.
When you start Lexapro, your body is adjusting to higher serotonin levels in the brain. Most side effects during this period are mild to moderate and often improve after 1–2 weeks.
By month two or three, many early side effects have decreased. However, some can persist or emerge later.
Stopping Lexapro abruptly can lead to:
To avoid withdrawal, your doctor will often taper your dose gradually.
While most side effects are manageable, seek medical attention right away if you experience:
For any troubling symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. Always follow up with your healthcare provider.
Most people tolerate Lexapro well, and many side effects improve after the first two weeks. By staying informed, tracking your symptoms, and communicating with your doctor, you’ll get the most benefit from treatment while minimizing discomfort.
If you ever feel that a side effect is severe, life-threatening, or affecting your daily life, do not hesitate to speak to a doctor. Your health and safety come first.
(References)
* Vari G, Beckson M. Escitalopram-associated serotonin toxicity. J Clin Psychopharmacol. 2007 Apr;27(2):229-30. doi: 10.1097/01.jcp.0000264977.64120.43. PMID: 17414259.
* Ram-Wolf C, Mahé E, Saiag P. Escitalopram photo-induced erythroderma. J Eur Acad Dermatol Venereol. 2008 Aug;22(8):1015-7. doi: 10.1111/j.1468-3083.2007.02513.x. Epub 2008 Jan 23. PMID: 18221340.
* Schwartz AR, Pizon AF, Brooks DE. Dextromethorphan-induced serotonin syndrome. Clin Toxicol (Phila). 2008 Sep;46(8):771-3. doi: 10.1080/15563650701668625. PMID: 19238739.
* Parker S, Nagarsekar BB. Escitalopram induced mania. Indian J Psychiatry. 2007 Apr;49(2):121-2. doi: 10.4103/0019-5545.33260. PMID: 20711395; PMCID: PMC2917077.
* Kasper S. Unique mechanism of action for escitalopram: does it hold the promise? Int J Psychiatry Clin Pract. 2004;8 Suppl 1:15-8. doi: 10.1080/13651500410005504. PMID: 24930684.
* Prabhakar D, Sablaban I. Escitalopram-Induced Rash. Prim Care Companion CNS Disord. 2019 Jan 31;21(1). doi: 10.4088/PCC.18l02302. Epub 2019 Jan 31. PMID: 30806996.
* AlJhani SA. Escitalopram-induced epistaxis: A case report. J Taibah Univ Med Sci. 2021 Dec;16(6):938-942. doi: 10.1016/j.jtumed.2021.06.004. Epub 2021 Jul 8. PMID: 34899137; PMCID: PMC8626811.
* Hussain M, Boyer K, Ponnapalli A, Awuah D, Khaneki S, Deliwala S, Bachuwa G. Serotonin Surge: Intravenous Escitalopram as a Rare Cause of Drug-Induced Aplastic Anaemia. Eur J Case Rep Intern Med. 2022;9(3):003228. doi: 10.12890/2022_003228. Epub 2022 Mar 4. PMID: 35402326; PMCID: PMC8988496.
* Johannesdottir A, Sigurdsson E. [The use of psilocybin for treatment-resistant depression]. Laeknabladid. 2022 Sep;108(9):403-410. doi: 10.17992/lbl.2022.09.706. PMID: 36040772.
* Liu Z, Yu S, Hu Y, Wang D, Wang S, Tang Z, Li W. Efficacy and safety of repeated transcranial magnetic stimulation combined with escitalopram in the treatment of major depressive disorder: a meta-analysis. Front Psychiatry. 2023;14:1275839. doi: 10.3389/fpsyt.2023.1275839. Epub 2024 Jan 3. PMID: 38234362; PMCID: PMC10791764.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.